Merk-Ahmad, K.; Bein, J.; Scharf, S.; Schäfer, H.; Bexte, T.; Ullrich, E.; Loth, A.G.; Flinner, N.; Senff, T.; Schneider, O.;
et al. The RHOA Mutation G17V Does Not Lead to Increased Migration of Human Malignant T Cells but Is Associated with Matrix Remodelling. Cancers 2023, 15, 3226.
https://doi.org/10.3390/cancers15123226
AMA Style
Merk-Ahmad K, Bein J, Scharf S, Schäfer H, Bexte T, Ullrich E, Loth AG, Flinner N, Senff T, Schneider O,
et al. The RHOA Mutation G17V Does Not Lead to Increased Migration of Human Malignant T Cells but Is Associated with Matrix Remodelling. Cancers. 2023; 15(12):3226.
https://doi.org/10.3390/cancers15123226
Chicago/Turabian Style
Merk-Ahmad, Katrin, Julia Bein, Sonja Scharf, Hendrik Schäfer, Tobias Bexte, Evelyn Ullrich, Andreas G. Loth, Nadine Flinner, Tina Senff, Olga Schneider,
and et al. 2023. "The RHOA Mutation G17V Does Not Lead to Increased Migration of Human Malignant T Cells but Is Associated with Matrix Remodelling" Cancers 15, no. 12: 3226.
https://doi.org/10.3390/cancers15123226
APA Style
Merk-Ahmad, K., Bein, J., Scharf, S., Schäfer, H., Bexte, T., Ullrich, E., Loth, A. G., Flinner, N., Senff, T., Schneider, O., Hansmann, M.-L., Piel, M., Häupl, B., Oellerich, T., Donnadieu, E., & Hartmann, S.
(2023). The RHOA Mutation G17V Does Not Lead to Increased Migration of Human Malignant T Cells but Is Associated with Matrix Remodelling. Cancers, 15(12), 3226.
https://doi.org/10.3390/cancers15123226